Hypocalcific factor (HCF) is a biologically active substance that is involved in the regulation of calcium levels in the blood. It belongs to the family of peptides, which is formed from the prohormone calcitonin, synthesized in the cells of the thyroid gland. The hypocalcic factor plays an important role in maintaining normal levels of calcium and phosphorus in the human body, and also affects the function of the cardiovascular system, muscles, bones and kidneys.
The main sources of GCF in the body are epithelial cells of the thyroid gland, pituitary gland and parathyroid glands. Normally, the hormone is constantly produced and accumulates in special depots located in the secretory granules of epithelial cells. If the level of GCF decreases, this can lead to the development of thyrotoxicosis, hypercalcemia, hypoglycemia and other pathological conditions.
One of the main mechanisms of action of GCF is its effect on blood calcium levels by stimulating calcium channels. This allows you to regulate metabolism in bones, muscles and other organs through the formation and release of various biologically active substances such as hormones, mediators and neurotransmitters.
The hypocalcemic factor is one of the active regulators of metabolic processes in the body; it is widely used in medicine and pharmacology for the treatment and prevention of various diseases associated with calcium metabolism disorders. These include hypocalcemia, osteoporosis, muscular dystrophy, arrhythmia and others. GCF is also used to diagnose calcium metabolism disorders in the body.
The use of GCF may be accompanied by side effects such as headache, nausea, dizziness and allergic reactions. However, when GCF is used correctly, these side effects are minimal and do not require treatment. In addition, an overdose of the drug can cause hypercalcemia, which can be dangerous to health and life. Therefore, doctors must strictly observe the dosage and time of taking the drug.
A GCF inhibitor is a substance that can block the activity of this hormone.